Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/16/2022
Adagene, Merck Gets FDA Blessing P1b/2 Trial of ADG126/Keytruda Combo
3/2/2022
Adagene and Sanofi Enter SAFEbody Multi-Target Collaboration for Nove...
3/1/2022
Heidelberg Pharma and Huadong Announce Strategic Partnership, Includin...
2/23/2022
Kiniksa Pharma and Huadong Medicine Announce Strategic Collaboration
2/14/2022
Chinese Drug Developers Look to Enter the U.S. Market through Out-lice...
2/13/2022
Innovent's Setback Warns Peers Prioritizing Pricing Not Good Tactic in...
2/11/2022
AKSO and Huadong Medicine Enter Strategic Collaboration to Develop/Com...
2/7/2022
Pfizer Sues Two Ex-employees for Trade Secret Theft, Implicating Qilu ...
2/7/2022
Why Chinese Drugmakers Fail to Reach for the STAR (PharmaDJ)
1/26/2022
NMPA Announces Package Insert Revision of Numerous Drug Products
1/26/2022
BfV Warns German Pharma and Tech Firms About Being Targeted by Hacker...
1/25/2022
Protecting Pharmaceutical Trademarks in China and Taiwan
1/19/2022
Anti-tumor Drugs Became the Hottest Treatments in December (PharmaDJ's...
1/17/2022
Licensing Moves Towards Early-Stage Assets in 2021: PharmaDJ
1/17/2022
Massive Series A Rounds in December 2021 Highlight New R&D Trends: Pha...
1/9/2022
2021 Wraps Up with Multi-billion Dollar Deals: PharmaDJ
1/3/2022
Third Former GSK Scientist Pleads Guilty to Stealing Trade Secrets to ...
12/21/2021
As U.S. Takes Aim at China Drug Makers, Innovators Appear at Biggest R...
12/20/2021
Novartis and BeiGene Expands Collaboration to BeiGene's TIGIT Inhibito...
12/16/2021
Zai Lab's NUZYRA Approved in China as a Class 1 New Drug for CABP and ...
12/13/2021
Chinese Couple Arrested in the U.S. for Scheme to Smuggle mRNA Cancer ...
12/13/2021
CDE: Annual Report on Clinical Trials for New Drug Registration in Chi...
12/13/2021
China's NRDL Explained: 67 New Drugs, 62% Price Cut, 80% Success Rate ...
12/7/2021
Sanofi Scores A Trademark Win in China
11/30/2021
Adagene Gains U.S. IND Approval for P1b/2 Trial of Anti-CTLA-4 mAb A...
11/26/2021
CDE Solicits Comments the Guidelines for Evaluation of Immune-Related ...
11/24/2021
API Manufacturers Targeted by China's New Anti-monopoly Bureau: Pharma...
11/23/2021
PharmaDJ's China Licensing Deals Tracker: October 2021
11/18/2021
China Healthcare Summit: Western Investors Expand into Chinese Biotech...
11/16/2021
PharmaDJ's China Biotech Fundraising Tracker: October 2021
Page:
7
/
26
Total number of articles:
751
:
[First]
[<<]
[5]
[6]
[7]
[8]
[9]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit